SCHEMBL598190

SCHEMBL598190

C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(O)CCO

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
G6PD P11413 3/20 0.64
SERPINA6 P08185 2/20 0.61
LMNA P02545 3/20 0.58
GPBAR1 Q8TDU6 3/20 0.58
CYP1A2 P05177 2/20 0.58
CYP3A4 P08684 2/20 0.58
CYP2C9 P11712 2/20 0.58
TSHR P16473 2/20 0.58
SHBG P04278 1/20 0.58
CYP2C19 P33261 1/20 0.58
HSD17B10 Q99714 1/20 0.58
ALDH1A1 P00352 1/20 0.55
MAPT P10636 1/20 0.55
PMP22 Q01453 1/20 0.55
KMT2A Q03164 1/20 0.55
NR1I3 Q14994 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19330943 1.00 G6PD (0.64) G6PDSERPINA6LMNAGPBAR1CYP1A2
SCHEMBL16431616 1.00 G6PD (0.64) G6PDSERPINA6LMNAGPBAR1CYP1A2
SCHEMBL598321 1.00 G6PD (0.64) G6PDSERPINA6LMNAGPBAR1CYP1A2
SCHEMBL1324961 0.93 G6PD (0.61) G6PDSERPINA6LMNAGPBAR1CYP1A2
SCHEMBL1324964 0.93 G6PD (0.61) G6PDSERPINA6LMNAGPBAR1CYP1A2
SCHEMBL16225749 0.90 G6PD (0.67) G6PDSERPINA6LMNAGPBAR1CYP1A2
SCHEMBL1869871 0.90 G6PD (0.67) G6PDSERPINA6LMNAGPBAR1CYP1A2
SCHEMBL9436439 0.90 G6PD (0.67) G6PDSERPINA6LMNAGPBAR1CYP1A2
SCHEMBL16226634 0.90 G6PD (0.67) G6PDSERPINA6LMNAGPBAR1CYP1A2
SCHEMBL4934329 0.90 G6PD (0.67) G6PDSERPINA6LMNAGPBAR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8114860-B2 3beta-hydroxy-5alpha/beta-pregnan - steroids antagonism against 3alpha-hydroxy-5alpha-pregnan-20-one; enhanced GABA mediated chloride flux but with low GABA antagonism, pregnanes with an acetate group in 3 or in 3, 20 and 21 position partially inhibit GABA's own effect on the GABA mediated chloride flux UMECRINE AB (SE) 2012-02-14 US disclosed